Loading...
XWAR
NEU
Market cap857mUSD
Apr 30, Last price  
712.00PLN
1D
-2.33%
1Q
-14.53%
Jan 2017
82.56%
Name

Neuca SA

Chart & Performance

D1W1MN
P/E
22.15
P/S
0.27
EPS
32.15
Div Yield, %
2.04%
Shrs. gr., 5y
-2.38%
Rev. gr., 5y
8.79%
Revenues
11.81b
+5.16%
1,414,766,0001,700,854,0003,288,786,0003,969,629,0005,687,344,0006,131,679,0006,388,658,0005,687,431,0005,795,092,0006,568,700,0006,945,703,0007,077,194,0007,485,234,0007,753,263,0008,278,727,0009,254,014,0009,864,258,00011,232,540,00011,812,636,000
Net income
146m
+6.58%
10,810,00011,275,00016,350,00014,104,00036,336,00037,563,00053,192,00066,016,00085,347,00093,070,000101,284,000111,727,00094,497,00098,274,000117,655,000141,791,000150,655,000137,238,000146,269,000
CFO
288m
-14.19%
13,200,000-11,013,00084,072,00035,614,00048,994,00014,111,000166,079,000124,920,00027,696,000202,556,000180,402,000175,049,000121,764,000121,935,000202,247,000324,671,000300,198,000335,937,000288,271,000
Dividend
Jun 12, 202414.5 PLN/sh
Earnings
May 20, 2025

Profile

NEUCA S.A. engages in the distribution of pharmaceuticals to pharmacies and hospitals in Poland. It operates through Pharmaceutical Wholesale; Own Brands; and Outpatient Care Clinics, Clinical Trials and Telemedicine segments. The company also provides advertising and marketing services; pharmaceutical products under its own brand; clinical trial, telemedicine, agency, financial, road cargo transport, accounting and bookkeeping, software, hospital, and information technology and computer related services; and health, property, and other personal insurance products. In addition, it operates outpatient care clinics and medical stores. The company was formerly known as Torfarm SA and changed its name to NEUCA S.A. in April 2010. NEUCA S.A. was founded in 1990 and is based in Torun, Poland.
URL
https://www.neuca.pl/
IPO date
Sep 30, 2004
Employees
3,981
Domiciled in
PL
Incorporated in
PL

Valuation

Title
PLN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
11,812,636
5.16%
11,232,540
13.87%
Cost of revenue
11,560,963
11,006,265
Unusual Expense (Income)
NOPBT
251,673
226,275
NOPBT Margin
2.13%
2.01%
Operating Taxes
44,330
54,359
Tax Rate
17.61%
24.02%
NOPAT
207,343
171,916
Net income
146,269
6.58%
137,238
-8.91%
Dividends
(58,229)
(51,565)
Dividend yield
1.40%
1.73%
Proceeds from repurchase of equity
2,922
(55,964)
BB yield
-0.07%
1.88%
Debt
Debt current
383,928
229,966
Long-term debt
461,153
323,736
Deferred revenue
Other long-term liabilities
72,599
188,248
Net debt
623,357
267,105
Cash flow
Cash from operating activities
288,271
335,937
CAPEX
(94,183)
(81,448)
Cash from investing activities
(257,027)
(180,219)
Cash from financing activities
(139,093)
(6,636)
FCF
202,153
(56,129)
Balance
Cash
119,547
225,867
Long term investments
102,177
60,730
Excess cash
Stockholders' equity
765,604
719,458
Invested Capital
1,793,233
1,489,512
ROIC
12.63%
12.43%
ROCE
14.03%
15.14%
EV
Common stock shares outstanding
4,503
4,575
Price
925.00
42.31%
650.00
-22.62%
Market cap
4,165,606
40.07%
2,973,860
-23.59%
EV
4,855,807
3,291,268
EBITDA
366,279
324,192
EV/EBITDA
13.26
10.15
Interest
84,342
47,733
Interest/NOPBT
33.51%
21.10%